(Date:1/8/2009)...iday, January 9 , , WASHINGTON, Jan. 8 /PRNews...rnational Union (SEIU) President Andy Stern conven...cutive Board to discuss the forced transfer of 65,...United Healthcare Workers-West (UHW), its third la...til tomorrow. , , According to reports, several...
(Date:1/8/2009)...ape new treatments for secondary pneumonia , , ...Scientists at St. Jude Children,s Research Hospita... bacterial pneumonia following influenza. They fou...in, which kill bacteria by inhibiting their protei...rst-line treatment with the "beta-lactam" antibiot...
(Date:1/8/2009)...search Hospital have demonstrated a more effective...enza. They found that the antibiotics clindamycin ...g their protein synthesis, are more effective than...ctam" antibiotic ampicillin, which causes the bact...tant because pneumonia, rather than the influenza ...
(Date:1/8/2009)...9 Continues Growth Trend , , NORTH HOLLYWOOD, C...spitalist Company, Inc. (Nasdaq: IPCM ), a leadi...ompany, announced today that it has acquired the h...nts, Inc. (MACC) in St. Louis, Missouri. The acqui...ouis market, where IPC has established a significa...
Breaking Medicine News(10 mins):Health News:SEIU Decision to Force Transfer of Long-Term Care Members Out of United Healthcare Workers Delayed 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 3Health News:Study finds more effective treatment for pneumonia following influenza 2Health News:Study finds more effective treatment for pneumonia following influenza 3Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2(Date:1/8/2009)... initial dose in an ongoing Phase Ib trial demonst...three days , , Conference Call Today at 8:30AM ...l/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS...f an ongoing Phase Ib clinical trial of ANA598, th...ase inhibitor. ANA598 was very well-tolerated and...
(Date:1/7/2009)...ts in Development Based On Osteotech,s Proprietary...oRegeneration; FDA Filing Anticipated in Third Qua...ire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OST...oducts for regenerative healing, announced today t...its DuraTech(TM) BioRegeneration Matrix. The first...
(Date:1/6/2009)...PRNewswire/ -- In recent controlled studies conduc... , scientists found that the patented ingredient i...ly proven ingredient to increase levels of nitric ...itrate/nitrate (NOx) in human subjects. , , Nit...rease in blood flow to the skeletal muscles. This...
(Date:1/6/2009)...ary 6 , - Early R...n Until,December 2011 , - Expansion of the...iscovery in Ophthalmology , - Revised Comme...ublicenses to a Third Party , ExonHit The...nforcement,of its existing drug discovery collabo...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Linkwell Corp to File to Extend Filing Date for 2007 Form 10 K 15566 1Linkwell Corp to File to Extend Filing Date for 2007 Form 10 K 15566 2National Press Club to Host NEWSMAKER Media Briefing on Improving the Cost of Healthcare with R Kerry Clark 15563 1Dynatronics Introduces New Synergie Elite Aesthetic Line 15560 1Dynatronics Introduces New Synergie Elite Aesthetic Line 15560 2Medical Mutual of Ohio Earns Top Accreditation for Product Excellence 15557 1Medical Mutual of Ohio Earns Top Accreditation for Product Excellence 15557 2...ereus,Pharmaceuticals, Inc., a pioneer in drug dis...es, and its collaborators will present,clinical an...rug,candidates at the American Association for Can...4-18. Four posters and two,minisymposia will highl...in several tumor models for three Nereus compounds...
...- Bentley,Pharmaceuticals, Inc. (NYSE: BNT), a spe...t its abstract entitled "Interim,Results of a Rand...tic Study of Intranasal Insulin Spray (Nasulin(TM)...ctable Fast-Acting,Insulin (Humalog(R)), and Salin...litus," has been selected for oral presentation at...
Other Medicine Technology:Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 2Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 3Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 4Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 5Nasulin Interim Results to Be Presented at American Diabetes,Association Scientific Sessions 2Nasulin Interim Results to Be Presented at American Diabetes,Association Scientific Sessions 3...Single Head Rectangular Camera ,IS2s Single ...ole body scans and SPECT studies. Offering flexibi...ingle Rectangular Head Camera is an ideal camera f...purpose work, and also acquires excellent cardiac ...
...Arctic Circler uses the same cryoconsole and platf...in the pulmonary veins. Arctic Circler is an ablat...liative-only treatments that rely on medication.,...catheter has the ability to create curvilinear les...
...Aneurysm occlusion is the ultimate objective of ne...num coils. With Matrix Detachable Coils, occlusion...ls are intended for embolization of those intracra..., their location, or the patient's general medical...
Tungsten Carbide wire twister.
Medicine Products: